Summary of the Conference Call on Brain-Computer Interface Technology Company and Industry Overview - The conference focused on Shanghai Aoyi Information Technology, which has been in the brain-computer interface (BCI) field for ten years, specializing in BCI and neural signal decoding technology, as well as core components for robotics [2][19]. Core Insights and Arguments - **Market Positioning**: Shanghai Aoyi is actively involved in medical applications of BCI technology, particularly for treating neurological diseases such as stroke. The company provides EEG machines for signal acquisition and analysis, and has developed smart prosthetic hands for amputees using non-invasive techniques [2][3]. - **Government Support**: The BCI technology has been recognized by the government as one of the six key industries for the future. Recent policy changes in cities like Shanghai and Beijing have included certain surgical procedures under medical insurance, which is expected to accelerate the application of BCI technology in healthcare [4][14]. - **Applications of BCI**: Current applications of BCI technology include treatment for neurological diseases (e.g., stroke, Alzheimer's, epilepsy), rehabilitation training, and human-computer interaction in industrial and military settings, as well as AR/VR entertainment [5][10]. - **Signal Acquisition Methods**: There are three main methods for acquiring neural signals: invasive, non-invasive, and peripheral electromyography. Invasive methods provide high-quality signals but come with significant risks, while non-invasive methods are safer but yield lower quality signals [6][7]. - **AI Integration**: AI plays a crucial role in optimizing signal processing in BCI technology, enhancing system accuracy and efficiency, and enabling real-time feedback and adjustments [20][21]. Additional Important Points - **Challenges in BCI**: The industry faces challenges related to effectiveness, safety, material science, and technical issues. Each surgical procedure requires follow-up to assess outcomes, and materials used must be soft yet removable to avoid damage to brain tissue [15][17]. - **Future Prospects**: The BCI industry is expected to see significant advancements by 2026, with several important certifications anticipated to facilitate the application of both implanted and non-implanted devices in medical settings [13][14]. - **Commercialization of Non-Invasive Devices**: Non-invasive devices, such as exoskeletons, are being developed and are expected to enter the market soon. However, high costs may limit their initial penetration, although prices are expected to decrease with technological advancements [16][29]. - **Collaboration with Redick**: Shanghai Aoyi is collaborating with Redick on advanced technologies, including AI algorithms and electric control systems, with plans for comprehensive cooperation in prosthetics, exoskeletons, and robotics [30]. This summary encapsulates the key points discussed during the conference, highlighting the advancements, challenges, and future outlook of the brain-computer interface industry and Shanghai Aoyi Information Technology's role within it.